TAK vs AAPL: Which Stock is Better?

Side-by-side comparison of Takeda Pharmaceutical Co Ltd and Apple Inc in 2026

Comparison Updated:

TAK

Takeda Pharmaceutical Co Ltd

$17.82

AAPL

Apple Inc

$270.52

Key Metrics Comparison

MetricTAKAAPLWinner
Market Cap$56.17BN/ATAK
P/E Ratio80.8233.34AAPL
EPS (TTM)$0.22$7.90AAPL
Revenue Growth0.0%0.2%AAPL
Gross Margin65.5%47.3%TAK

Analyze TAK

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is TAK or AAPL a better investment?

Comparing TAK and AAPL: Takeda Pharmaceutical Co Ltd has a market cap of $56.17B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between TAK and AAPL?

TAK (Takeda Pharmaceutical Co Ltd) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: TAK or AAPL?

Based on P/E ratios, AAPL trades at a lower multiple (33.3x vs 80.8x).

Which is growing faster: TAK or AAPL?

AAPL has higher revenue growth at 0.2% vs 0.0% for TAK.

Which company is more profitable: TAK or AAPL?

Takeda Pharmaceutical Co Ltd (TAK) has higher gross margins at 65.5% compared to 47.3% for AAPL.

Which is the larger company: TAK or AAPL?

Takeda Pharmaceutical Co Ltd (TAK) is larger with a market cap of $56.17B compared to N/A for AAPL.

Should I buy TAK or AAPL in 2026?

Both TAK and AAPL have investment merit. TAK trades at $17.82 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between TAK and AAPL stock?

Key differences: Market Cap ($56.17B vs N/A), P/E Ratio (80.8x vs 33.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (65.5% vs 47.3%).

Popular Stock Comparisons